Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
5Annual filing director officer or owner of more than ten percent.Feb 4, 2015Open Annual filing director officer or owner of more than ten percent. in HTML.Open Annual filing director officer or owner of more than ten percent. in DOC file.Open Annual filing director officer or owner of more than ten percent. in PDF file.Open Annual filing director officer or owner of more than ten percent. in XLS file.
5Annual filing director officer or owner of more than ten percent.Feb 3, 2015Open Annual filing director officer or owner of more than ten percent. in HTML.Open Annual filing director officer or owner of more than ten percent. in DOC file.Open Annual filing director officer or owner of more than ten percent. in PDF file.Open Annual filing director officer or owner of more than ten percent. in XLS file.
4/AAmendment to a previously filed 4Jan 28, 2015Open Amendment to a previously filed 4 in HTML.Open Amendment to a previously filed 4 in DOC file.Open Amendment to a previously filed 4 in PDF file.Open Amendment to a previously filed 4 in XLS file.
4Statement of changes in beneficial ownership of securitiesJan 13, 2015Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
1-25      26-50      51-75      76-79

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information